qingxin mu
BrYet US, Inc.
Houston, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Editors
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Associate Editors
kazuto nishio
Kindai University
Higashi-osaka, Japan
Associate Editor
Cancer Molecular Targets and Therapeutics
l'houcine ouafik
Faculté de Médecine, Aix Marseille Université
Marseille, France
Associate Editor
Cancer Molecular Targets and Therapeutics
thomas ollila
Warren Alpert Medical School, Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
yunbao pan
Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University
Wuhan, China
Associate Editor
Cancer Molecular Targets and Therapeutics
panagiotis papageorgis
European University Cyprus
Engomi, Cyprus
Associate Editor
Cancer Molecular Targets and Therapeutics
jason luke parsons
University of Birmingham
Birmingham, United Kingdom
Associate Editor
Cancer Molecular Targets and Therapeutics
edyta agnieszka pawlak
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences
Wrocław, Poland
Associate Editor
Cancer Molecular Targets and Therapeutics
maurizio pellecchia
University of California, Riverside
Riverside, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
zoi piperigkou
Department of Chemistry, School of Science, University of Patras
Patras, Greece
Associate Editor
Cancer Molecular Targets and Therapeutics
ruth plummer
Newcastle University
Newcastle upon Tyne, United Kingdom
Associate Editor
Cancer Molecular Targets and Therapeutics
vivek m rangnekar
University of Kentucky
Lexington, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
annamaria rapisarda
Other
Frederick, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
michel rigaud
Laboratory of Biosciences, Scientific Institute of Romagna for the Study and Treatment of Tumors (IRCCS)
Meldola, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
alessandro rimessi
University of Ferrara
Ferrara, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
lori rink
Fox Chase Cancer Center
Philadelphia, United States
Associate Editor
Cancer Molecular Targets and Therapeutics